N/ARecruiting
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
Sponsored by Orchestra BioMed, Inc
About this study
A prospective, multinational, randomized, double-blind, clinical trial evaluating the safety and effectiveness of a novel atrioventricular interval modulation (AVIM) algorithm downloaded into a dual-chamber Medtronic Astra/Azure pacemaker.
Enrolling at this location
University of Chicago
Chicago, Illinois
I'm interestedThis study also enrolls at 71 other locations. See all.
Completing a questionnaire on Clinably does not enroll you in a clinical trial or confirm your eligibility. Only the research team can determine whether you qualify to participate. These results are based on the information you provide and are intended to help you start a conversation with the research team.
Trial data sourced from ClinicalTrials.gov.